A study published Monday in the journal Nature Communications claimed that scientists have created a monoclonal antibody that can defeat the new coronavirus in the lab. The news appears to be an effective treatment to combat the pandemic’s spread.
The antibody has neutralized the virus in cell cultures which may help to prevent or treat COVID-19 in future either alone or in a drug combination. More research is required to check whether the reports are confirmed in a clinical setting and how precisely the antibody defeats the virus, wrote Berend-Jan Bosch of Utrecht University in the Netherlands and colleagues in the paper.
As per reports, the antibody, known as 47D11, targets the spike protein that gives the novel coronavirus a crown-like shape and helps it to enter the human body. It not only defeats the virus responsible for COVID-19 but also a cousin equipped with similar spike proteins, which causes Severe Acute Respiratory Syndrome, or SARS.
“Monoclonal antibodies targeting vulnerable sites on viral surface proteins are increasingly recognized as a promising class of drugs against infectious diseases and have shown therapeutic efficacy for a number of viruses,” Bosch and colleagues wrote.